DPCPX

CAS No. 102146-07-6

DPCPX( PD 116948 )

Catalog No. M23228 CAS No. 102146-07-6

DPCPX is an A1 adenosine receptor antagonist

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 43 In Stock
5MG 29 In Stock
10MG 39 In Stock
25MG 62 In Stock
50MG 91 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    DPCPX
  • Note
    Research use only, not for human use.
  • Brief Description
    DPCPX is an A1 adenosine receptor antagonist
  • Description
    DPCPX is an A1 adenosine receptor antagonist.
  • In Vitro
    ——
  • In Vivo
    DPCPX (PD 116948) ( 0.1, 0.3 and 1.0 mg/kg i.v. ) produces significant dose-related increases (P<0.05) in urine volume and in urinary sodium, potassium and chloride excretion.
  • Synonyms
    PD 116948
  • Pathway
    Apoptosis
  • Target
    Adenosine Receptor
  • Recptor
    A1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    102146-07-6
  • Formula Weight
    304.39
  • Molecular Formula
    C16H24N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:<1 mg/mL;Ethanol:<1 mg/mL
  • SMILES
    CCCN(c1c(C(N2CCC)=O)[nH]c(C3CCCC3)n1)C2=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Aleksandra S , Ewa P , Karolina B , et al. DPCPX, a selective adenosine A1 receptor antagonist, enhances the antidepressant-like effects of imipramine, escitalopram, and reboxetine in mice behavioral tests[J]. Naunyn-Schmiedeberg's Archives of Pharmacology, 2018:1-11.
molnova catalog
related products
  • TP455

    TP455 (TP-455) is a highly potent, selective A2A adenosine receptor inverse agonist with IC50 of 1.9 nM in cyclic AMP assays in hA2A CHO cells.

  • Metipranolol

    Metipranolol is a β-adrenergic receptor antagonist that is given orally for the treatment of hypertension and also applied topically to the cornea for treating glaucoma.

  • CI-947

    An orally active adenosine receptor agonist that can induce acute cardiovascular toxicity and coronary vascular injury in vivo.